echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Fda enforcement exposed a batch of unqualified drink tablets, the New Deal frequently under the industry supervision tightened

    Fda enforcement exposed a batch of unqualified drink tablets, the New Deal frequently under the industry supervision tightened

    • Last Update: 2020-05-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In order
    to strengthen drug quality supervision and ensure the safety of public drug use, china's multi-provincial and municipal drug regulatory departments have carried out drug supervision and sampling throughout the provinceRecently, another batch of Chinese medicine drink tablets were sampled out of the unqualifiedA batch of unqualified drink tablets were exposedYunnan Province: 12 varietiesRecently, Yunnan Provincial Drug Administration issued the first issue of 2020 non-conforming drug quality announcement, sampling found that there are 12 varieties of Gegen, Tianma, Zhebei mother, etcunqualified, areChinese medicineand Chinese medicine drink tabletsHunan Province: 37 varieties
    Hunan Provincial Drug Administration recently organized the province's production, operation, use of drugs for spot checksThe sampling found that there were 38 batches of drugs that did not meet the regulations, involving 37 varieties of 32 production enterprisesXinjiang: 44 batches ofrecently, the Xinjiang Drug Administration issued 2 drug quality announcements, a total of 47 batches of non-conforming drugs were announced, involving 28 enterprisesAmong them, non-conforming drugs include 44 batches of Chinese medicine tablets, involving 26 pharmaceutical companiesIts non-conforming items include traits, identification, total ash, content determination and so onAnd there are 19 batches of Chinese medicine tablets note for non-enterprise productsShandong Province: 7 batches ofthe new drug quality sampling notice issued by the Shandong Provincial Drug Administration (2020 No2) shows that, after verification and confirmation, 10 varieties of 10 production enterprises (preparation units) marked a total of 10 batches of drugs, after sampling does not meet the standard requirementsAmong the unqualified drugs, there are 7 batches of Chinese medicine tablets, involving 5 varietiesHenan: 15 batches ofHenan Province Drug Administration also recently issued a notice of non-conforming drugsThe circular showed that 15 batches of medicinal herbs were not qualified, due to the above-standard pesticide residues and acid insoluble ash, total ash, free vantium, and non-compliance with the base valueThe supervision of the drinking film industry will become increasingly strict
    Chinese medicine tablets can be said to be the "regular customers" in the list of drug sampling failuresIndustry analysis pointed out that at present, many Chinese herbal medicine cultivation technology is not mature, coupled with the origin of medicinal herbs, defects in the concocting process, improper storage and other factors, may lead to Chinese medicine tablet sin sin sin items do not meet the requirementsBecause the quality of Chinese medicine tablets is related to clinical efficacy and patient safety, so it is very necessary to strengthen the rectification of the drinking tablet industry, to carry out better regulation and supervisionthe release of the newly revised Drug Administration Law in 2019, the Chinese medicine drink tablet industry reshuffle intensified, a number of small and medium-sized enterprises that do not meet the requirements of the regulations gradually withdraw from the market Recently, the State Drug Administration also held a teleconference to summarize the 2019 Chinese medicine drink tablets centralized rectification work and the 2020 Chinese medicine drink tablets special rectification work to do the deployment and mobilization it is clear that the special rectification activities of Chinese medicine tablets is one of the four special rectification activities in the 2020 drug safety supervision work plan of the State Drug Administration, and in February this year, a special issue of the "Chinese medicine drink tablets special rectification work programme", the program put forward the overall goal and work points for the special rectification work meeting requires that drug regulatory departments at all levels should, as required, unify their thinking, take concerted action, implement the responsibility of territorial supervision, carefully inspect the production and operation and use units of Chinese medicine tablets and preparations, resolutely investigate and punish illegal and illegal acts;  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.